Advanced breast biopsy instrumentation (ABBI) and management of nonpalpable XXXX : a community hospital experience.

@entity1 @entity1137 @entity5 @entity189 @entity513 @entity1558
A range of diagnostic techniques have been in use for determining the nature of non-palpable mammographic abnormalities over the last decade, these include stereotactic and ultrasound guided cytology, core biopsy and vacuum assisted core biopsy techniques as well as open surgical breast biopsy. Recently, a less invasive alternative has been investigated; the Advanced Breast Biopsy Instrumentation (ABBI) technique (U.S. Surgical Corporation, Norwalk, CT). ABBI employs computer-guided stereotactic localization to target and excise mammographic lesions under local anesthesia, without the need for an operating theatre. We conducted a prospective review of all cases involving the use of the ABBI system during the first 17 months' of its use in a community hospital. One hundred and twenty six @entity1 were referred for an ABBI procedure. One hundred fourteen ABBI procedures were performed on 113 @entity1 (average age, 53 years; range, 33-82). The lesion was removed successfully in 113 of the 114 cases. Of the 114 lesions removed with the ABBI system, 88 were microcalcifications and 26 were masses. @entity5 was diagnosed in 21 @entity1 (18%). Of the @entity1 who had @entity189 , 11 (52%) had @entity513 in situ, 9 (43%) had infiltrating @entity513 , and 1 (5%) had @entity1137 . Postprocedural complications occurred in 7 @entity1 (6%); 4 had small haematomas, 2 had superficial wound infections, and 1 had an abscess. We conclude that the ABBI system, is an excellent alternative (to open biopsy after needle localization or large-core biopsy) for nonpalpable @entity1558 . It has a relatively low complication rate and should be considered as part of the surgical armamentarium for the diagnosis of indeterminate nonpalpable mammographic lesions.
